skip to navigation skip to content
Search

An interview with Mark Kotter, the founder and CEO of Bit Bio biotechnology company. Bit Bio aims to develop a scalable technology platform capable of producing consistent batches of every human cell. The startup is supported by the Accelerate Cambridge programme run by Cambridge Judge’s Entrepreneurship Centre.

Read the full article [forbes.com]